Discover comprehensive details about Solifenacin, including its pronunciation, uses, dosage instructions, indications, and guidelines on how and when to take it or avoid it. The updated prescription ...

Antimuscarinics have remained the standard of care for patients with overactive bladder (OAB) syndrome for several decades, despite the fact that, owing to their adverse effects, these drugs are ...

The US Food and Drug Administration (FDA) has approved mirabegron (Myrbetriq, Astellas Pharma) in combination with solifenacin succinate (Vesicare, Astellas Pharma) for the treatment of overactive ...

Solifenacin (Bispec (10 mg)) is a urinary antispasmodic agent, prescribed for overactive bladder with or without incontinence.It works by blocking the action of certain chemicals in the body to help ...

Astellas Pharma announced results from the Phase 3b BESIDE trial of solifenacin (SOLI) with mirabegron (MIRA) as an add-on therapy in incontinent overactive bladder (OAB) patients. The BESIDE study is ...

NEW ORLEANS — For patients with overactive bladder, the addition of mirabegron (Myrbetriq, Astellas Pharma) to solifenacin (Vesicare, Astellas Pharma) appears to confer added control and benefit ...

Solifenacin succinate 5mg, 10mg; tabs. A competitive muscarinic receptor antagonist. Muscarinic receptors play an important role in several major cholinergically mediated functions, including ...

Do not use if you have ever had an allergic reaction to SOLIFENACIN VIATRIS or any of the ingredients listed at the end of the CMI. There are a number of circumstances in which a person should not use ...